Home
Forums
New posts
Contact Us
What's new
New posts
New media
New media comments
Latest activity
Media
New media
New comments
Search media
Search All
Members
Current visitors
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Contact Us
Menu
Log in
Register
Install the app
Install
Forums
Really good
Life
A First Step for a Family Biotech’s Vaccine Against Alzheimer’s
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="cheryl" data-source="post: 796" data-attributes="member: 1"><p><strong>A First Step for a Family Biotech’s Vaccine Against Alzheimer’s - Bloomberg<a href="https://www.bloomberg.com/news/articles/2019-01-16/united-neuroscience-s-alzheimer-vaccine-just-might-work" target="_blank">Bloomberg - Are you a robot?</a></strong></p><p></p><p><em>United Neuroscience’s small Phase II trial appears to have overcome a decades-old hurdle. </em></p><p></p><p>For two decades, biotech companies trying to tackle <a href="https://www.bloomberg.com/quicktake/alzheimers-disease" target="_blank"> Alzheimer’s disease</a> have had little success. While vaccines have often shown promise for certain patients, they’ve come with devastating side effects for others—brain swelling, for example—because researchers haven’t been able to reliably keep patients’ immune systems from kicking into overdrive when exposed to the vaccines. Now, a four-year old Dublin startup believes it may be on to something.</p><p></p><p>To be clear, United Neuroscience Inc. hasn’t solved Alzheimer’s yet, nor has it claimed to. But previously unreported results from a small, recent United clinical trial show that 96 percent of patients responded, without serious side effects, to the Alzheimer’s vaccine the company calls UB-311. The patients demonstrated improved brain function and showed a reduction in the protein plaque gumming up their neurons, the company’s report says. “We are doing better than the placebo on all these things,” says Chief Executive Officer Mei Mei Hu. “We can’t make any claims yet, but we’re pointing in all the right directions.”</p></blockquote><p></p>
[QUOTE="cheryl, post: 796, member: 1"] [B]A First Step for a Family Biotech’s Vaccine Against Alzheimer’s - Bloomberg[URL="https://www.bloomberg.com/news/articles/2019-01-16/united-neuroscience-s-alzheimer-vaccine-just-might-work"]Bloomberg - Are you a robot?[/URL][/B] [I]United Neuroscience’s small Phase II trial appears to have overcome a decades-old hurdle. [/I] For two decades, biotech companies trying to tackle [URL='https://www.bloomberg.com/quicktake/alzheimers-disease'] Alzheimer’s disease[/URL] have had little success. While vaccines have often shown promise for certain patients, they’ve come with devastating side effects for others—brain swelling, for example—because researchers haven’t been able to reliably keep patients’ immune systems from kicking into overdrive when exposed to the vaccines. Now, a four-year old Dublin startup believes it may be on to something. To be clear, United Neuroscience Inc. hasn’t solved Alzheimer’s yet, nor has it claimed to. But previously unreported results from a small, recent United clinical trial show that 96 percent of patients responded, without serious side effects, to the Alzheimer’s vaccine the company calls UB-311. The patients demonstrated improved brain function and showed a reduction in the protein plaque gumming up their neurons, the company’s report says. “We are doing better than the placebo on all these things,” says Chief Executive Officer Mei Mei Hu. “We can’t make any claims yet, but we’re pointing in all the right directions.” [/QUOTE]
Verification
Post reply
Forums
Really good
Life
A First Step for a Family Biotech’s Vaccine Against Alzheimer’s
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top